Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 20 of 35
Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
NCT02848872
Optical Spectroscopy for Cutaneous Cancer
NCT02522793
Transcutaneous Autonomic Modulation in Thoracic Surgery
NCT02783157
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer
NCT02580045
The Effect of Reducing Posttraumatic Stress Disorder Symptoms on Cardiovascular Risk
NCT02736929
Incentivizing Behavior Change Skills to Promote Weight Loss
NCT02691260
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
NCT02697916
Duke Scleroderma Clinic Patient Registry
NCT02851875
Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers
NCT02599571
Analgesic Value of Adductor Canal vs Femoral Block After Total Knee Arthroplasty
NCT03395990
Chronic Endometritis and IVF
NCT02646930
Preoperative Pain Threshold and Rapid Recover Programs
NCT02740738
NCCN Renal Cell Registry
NCT02677337
Heart Rate Sensing and Response in Persons With Anorexia Nervosa
NCT02579018
iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes
NCT02980627
Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study
NCT02573246
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
NCT02701361
TMS Modulation of Insula-related Brain Networks
NCT02689323
Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study
NCT02528331
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
NCT02461602
CTTI Risk Factors for HABP/VABP Study
NCT02689531
Correlation of Spinopelvic Parameters and Acetabular Cup Orientation
NCT02598700
Addressing Tobacco Use Disparities Through an Innovative Mobile Phone Intervention
NCT02613689
VTE Prophylaxis Guidelines in Hospitalized Elders
NCT03025100
Single Breath Hold Abdominal MRI
NCT02434471
Efficacy of First Time Anterior Shoulder Decision Tool
NCT02656277
Examining the Role of Expressive Writing (EW) to Improve Resilience
NCT02510898
Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)
NCT02551692
Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma
NCT02694965
Biopsychosocial Influence on Shoulder Pain
NCT02620579
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
NCT02616133
Neurocognition, Lifestyle Modification, and Treatment Resistant Hypertension
NCT03001427
Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.
NCT02470728
Addressing Tobacco Use Disparities in Rural Older Adults Through an Innovative Mobile Phone Intervention
NCT02510716
Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
NCT02516332
Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study
NCT02471794
Pacing in First-degree AV-block
NCT01985802
Pompe Telemedicine Developmental Study
NCT02950298
Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair
NCT02575846
Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy
NCT02407977
Patient Centered Results for Uterine Fibroids
NCT02260752
Understanding Adaptive Challenges Associated With Male-factor Infertility
NCT02607098
Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain
NCT02439437
Prospective Subtalar, Double, or Triple Arthrodesis Study With CCS Screws
NCT02619838
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
NCT02569528
Measuring Fatigue in Triage: A Pilot Study
NCT02519205
Point of Care 3D Ultrasound for Pediatric Appendicitis: a Pilot Study
NCT02507674
Integrated Child Obesity Treatment Study: Bull City Healthy and Fit
NCT02573142
Platelets as Regulators of Inflammation in Cardiac Surgery
NCT02568410
Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners
NCT02574507
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.